Please use this identifier to cite or link to this item:
http://hdl.handle.net/2445/175684
Title: | Hepatorenal syndrome: pathophysiology, diagnosis, and management |
Author: | Simonetto, Douglas A. Ginès i Gibert, Pere Kamath, Patrick S. |
Keywords: | Malalties del ronyó Diagnòstic Kidney diseases Diagnosis |
Issue Date: | 14-Sep-2020 |
Publisher: | BMJ Publishing Group |
Abstract: | Hepatorenal syndrome (HRS), the extreme manifestation of renal impairment in patients with cirrhosis, is characterized by reduction in renal blood flow and glomerular filtration rate. Hepatorenal syndrome is diagnosed when kidney function is reduced but evidence of intrinsic kidney disease, such as hematuria, proteinuria, or abnormal kidney ultrasonography, is absent. Unlike other causes of acute kidney injury (AKI), hepatorenal syndrome results from functional changes in the renal circulation and is potentially reversible with liver transplantation or vasoconstrictor drugs. Two forms of hepatorenal syndrome are recognized depending on the acuity and progression of kidney injury. The first represents an acute impairment of kidney function, HRS-AKI, whereas the second represents a more chronic kidney dysfunction, HRS-CKD (chronic kidney disease). In this review, we provide critical insight into the definition, pathophysiology, diagnosis, and management of hepatorenal syndrome. |
Note: | Reproducció del document publicat a: https://doi.org/10.1136/bmj.m2687 |
It is part of: | British Medical Journal, 2020, num. 370, p. m2687 |
URI: | http://hdl.handle.net/2445/175684 |
Related resource: | https://doi.org/10.1136/bmj.m2687 |
ISSN: | 0959-8146 |
Appears in Collections: | Articles publicats en revistes (Medicina) Articles publicats en revistes (IDIBAPS: Institut d'investigacions Biomèdiques August Pi i Sunyer) |
Files in This Item:
File | Description | Size | Format | |
---|---|---|---|---|
705291.pdf | 303.36 kB | Adobe PDF | View/Open |
This item is licensed under a Creative Commons License